Officials did not release the names of the facilities included in the transaction. The financial terms of the transaction were not disclosed.
Amedisys has announced six acquisitions since December 2015, deploying roughly $125 million in capital and contributing approximately $145 million in revenue.
“This acquisition gives Amedisys an incredible opportunity to continue our goal of providing high quality post-acute services in key markets,” said Amedisys President and CEO Paul Kusserow. “We look forward to the opportunity to work with Tenet in these markets to improve the delivery of care and management of patients across the care continuum.”
Trevor Fetter, chairman and CEO of Tenet Healthcare, emphasized the importance of transitioning ownership of the facilities so that patients may receive the best care possible, stating “Amedisys shares our commitment to serving patients, employees and the community. We are transferring these local operations of healthcare service providers to Amedisys so that high quality home health and hospice services will continue to be available within the communities they serve.”
More articles on healthcare transactions and valuations:
74 healthcare transactions and partnerships in February
5 most-read transactions and valuations stories in February
MSU HealthTeam joins national comprehensive care partnership
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
